NCT03541694View on ClinicalTrials.gov

Passive Enhanced Safety Surveillance of Stamaril® Vaccine in Korea

CompletedOBSERVATIONAL
Enrollment

622

Participants

Timeline

Start Date

April 11, 2018

Primary Completion Date

May 30, 2018

Study Completion Date

May 30, 2018

Conditions
Yellow Fever
Interventions
BIOLOGICAL

Stamaril®

Routine vaccination with Stamaril yellow fever vaccine

Trial Locations (1)

04564

Sanofi Pasteur Investigational Site 001, Seoul

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT03541694 - Passive Enhanced Safety Surveillance of Stamaril® Vaccine in Korea | Biotech Hunter | Biotech Hunter